Leading Diagnostic Healthcare Company Signs Contract Manufacturing Agreement in Order to Fulfill Sales of IgE and Lactoferrin DED Diagnostic Assays Until this agreement, the Company has been ...
SAN DIEGO, CA, March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company ...
SAN DIEGO, CA, May 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire-- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an ...
SAN DIEGO, Jan. 22, 2020 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
SAN DIEGO, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – AXIM Biotechnologies, Inc (AXIM). (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the ...
AXIM Biotechnolgies, Inc. is beginning human dermatological clinical trials for Cannabinoid based solutions for psoriasis and eczema. The trials will be conducted at The Maurits Clinic in The Hague, ...
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
(Reuters) - AXIM Biotechnologies Inc, a small, Manhattan-based company with ties to the Netherlands, says it has a trump card in its quest to develop a cannabis-based chewing gum to ease the symptoms ...
Axim Biotechnologies Inc. Annual stock financials by MarketWatch. View the latest AXIM financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results